Search research articles
Contact Us
Filters
Showing results (491-500 of 517) with videos related to
Page
of 52
Sort By:
Science Advances
|
February 19, 2019
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease
Nicholas J Ashton, Alejo J Nevado-Holgado, Imelda S Barber, et al.
JAMA Neurology
|
November 4, 2024
Deferiprone in Alzheimer Disease: A Randomized Clinical Trial
Scott Ayton, David Barton, Bruce Brew, et al.
Molecular Psychiatry
|
September 22, 2023
Tau suppresses microtubule-regulated pancreatic insulin secretion
Salvatore P Mangiafico, Qing-Zhang Tuo, Xiao-Lan Li, et al.
Proteomics
|
April 15, 2010
A domain level interaction network of amyloid precursor protein and Abeta of Alzheimer's disease
Victoria M Perreau, Sandra Orchard, Paul A Adlard, et al.
International Psychogeriatrics
|
November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
Cell Metabolism
|
February 5, 2022
Selenium mediates exercise-induced adult neurogenesis and reverses learning deficits induced by hippocampal injury and aging
Odette Leiter, Zhan Zhuo, Ruslan Rust, et al.
Acta Neuropathologica Communications
|
September 30, 2021
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease
David I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Neuron
|
July 11, 2008
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta
Paul A Adlard, Robert A Cherny, David I Finkelstein, et al.
Acta Neuropathologica Communications
|
June 30, 2017
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease
David I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Signal Transduction and Targeted Therapy
|
February 24, 2022
Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion
Qing-Zhang Tuo, Yu Liu, Zheng Xiang, et al.
Page
of 52
Search research articles
Search
Showing results (491-500 of 517) with videos related to
Sort By:
Page
of 52
Science Advances
|
February 19, 2019
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease
Nicholas J Ashton, Alejo J Nevado-Holgado, Imelda S Barber, et al.
JAMA Neurology
|
November 4, 2024
Deferiprone in Alzheimer Disease: A Randomized Clinical Trial
Scott Ayton, David Barton, Bruce Brew, et al.
Molecular Psychiatry
|
September 22, 2023
Tau suppresses microtubule-regulated pancreatic insulin secretion
Salvatore P Mangiafico, Qing-Zhang Tuo, Xiao-Lan Li, et al.
Proteomics
|
April 15, 2010
A domain level interaction network of amyloid precursor protein and Abeta of Alzheimer's disease
Victoria M Perreau, Sandra Orchard, Paul A Adlard, et al.
International Psychogeriatrics
|
November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
Cell Metabolism
|
February 5, 2022
Selenium mediates exercise-induced adult neurogenesis and reverses learning deficits induced by hippocampal injury and aging
Odette Leiter, Zhan Zhuo, Ruslan Rust, et al.
Acta Neuropathologica Communications
|
September 30, 2021
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease
David I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Neuron
|
July 11, 2008
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta
Paul A Adlard, Robert A Cherny, David I Finkelstein, et al.
Acta Neuropathologica Communications
|
June 30, 2017
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease
David I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Signal Transduction and Targeted Therapy
|
February 24, 2022
Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion
Qing-Zhang Tuo, Yu Liu, Zheng Xiang, et al.
Page
of 52